Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0032 | 0.452744765139 | 0.7068 | 0.77 | 0.685 | 603961 | 0.72989605 | CS |
| 4 | -0.0399 | -5.32070942792 | 0.7499 | 0.77365 | 0.66 | 524289 | 0.72872407 | CS |
| 12 | -0.279 | -28.2103134479 | 0.989 | 1.04 | 0.66 | 642946 | 0.81965879 | CS |
| 26 | -0.81 | -53.2894736842 | 1.52 | 1.66 | 0.66 | 691355 | 1.06885895 | CS |
| 52 | -1.14 | -61.6216216216 | 1.85 | 2.31 | 0.66 | 923076 | 1.35232005 | CS |
| 156 | -0.75 | -51.3698630137 | 1.46 | 2.31 | 0.5 | 816953 | 1.14597634 | CS |
| 260 | -0.42 | -37.1681415929 | 1.13 | 9.8 | 0.5 | 3596784 | 3.13771412 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
